Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision tag in the footer was updated from v3.6.5 to v3.6.6. This reflects a minor maintenance update to the page.
    Difference
    0.0%
    Check dated 2026-08-31T23:47:26.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision label in the page footer updated from v3.6.4 to v3.6.5, indicating a minor page version update. This is a metadata change that does not alter the study information displayed.
    Difference
    0.0%
    Check dated 2026-08-10T13:49:50.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The footer revision text changed from v3.6.3 to v3.6.4, indicating a new version of the site interface.
    Difference
    0.0%
    Check dated 2026-07-27T05:37:37.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The record history now lists revision v3.6.3 as the current version, updating the page's metadata.
    Difference
    0.0%
    Check dated 2026-07-05T13:16:37.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.0 to v3.6.2. This reflects a new revision published in the history rather than a substantive change to content.
    Difference
    0.0%
    Check dated 2026-06-28T04:50:38.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    The history now shows that enrollment is closed ('No longer looking for participants'), adds a new revision entry 'Revision: v3.6.0', and removes the previous revision entry 'Revision: v3.5.5' from the record.
    Difference
    0.1%
    Check dated 2026-06-13T17:33:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.